| Metric | Q4 2024 | Q3 2024 | Q4 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $2.5B | $3.3B | $3.4B | -23.6% | -24.4% |
| Op. Income | $479M | $1.0B | $1.5B | -53.9% | -67.9% |
| Gross Margin | 47.6% | 52.5% | 64.1% | -4.9pp | -16.5pp |
| Net Margin | 16.0% | 24.7% | 35.3% | -8.7pp | -19.3pp |
| EPS (Diluted) | $2.57 | $5.20 | $7.50 | -50.6% | -65.7% |
| Free Cash Flow | $638M | $906M | $569M | -29.6% | 12.1% |
| Item | Amount |
|---|---|
| REVENUE | $2.5B |
| Cost of Revenue | $1.3B |
| GROSS PROFIT | $1.2B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $729M |
| Operating Expenses | $729M |
| Cost & Expenses | $2.1B |
| OPERATING INCOME | $479M |
| Interest Income | $278M |
| Interest Expense | $13M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $479M |
| Income Tax Expense | $74M |
| NET INCOME | $405M |
| D&A | $15M |
| EBIT | $492M |
| EBITDA | $507M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $2.5B |
| Cost of Revenue | $1.3B |
| GROSS PROFIT | $1.2B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $729M |
| Operating Expenses | $729M |
| Cost & Expenses | $2.1B |
| OPERATING INCOME | $479M |
| Interest Income | $278M |
| Interest Expense | $13M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $479M |
| Income Tax Expense | $74M |
| NET INCOME | $405M |
| D&A | $15M |
| EBIT | $492M |
| EBITDA | $507M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $405M |
| Depreciation & Amortization | $15M |
| Stock-Based Compensation | $51M |
| Deferred Income Tax | -$82M |
| Other Non-Cash Items | $91M |
| Change in Working Capital | $162M |
| OPERATING CASH FLOW | $642M |
| Capital Expenditure | -$4M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$2.3B |
| Sales/Maturities of Investments | $1.1B |
| Other Investing Activities | -$5M |
| NET CASH FROM INVESTING | -$1.2B |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$5M |
| Common Dividends Paid | -$125M |
| Other Financing Activities | -$74M |
| NET CASH FROM FINANCING | -$204M |
| FREE CASH FLOW | $638M |
| Net Change in Cash | -$769M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $983M |
| Short-Term Investments | $16.5B |
| Net Receivables | $3.8B |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $21.4B |
| PP&E (Net) | $214M |
| Goodwill | $0 |
| Intangible Assets | $1.2B |
| Long-Term Investments | $11.9B |
| Tax Assets | $0 |
| Other Non-Current Assets | $1.8B |
| TOTAL NON-CURRENT ASSETS | $15.1B |
| TOTAL ASSETS | $36.5B |
| Account Payables | $0 |
| Short-Term Debt | $25M |
| Deferred Revenue | $4.8B |
| Other Current Liabilities | $11.5B |
| TOTAL CURRENT LIABILITIES | $16.3B |
| Long-Term Debt | $790M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $1.5B |
| Other Non-Current Liabilities | $3.9B |
| TOTAL NON-CURRENT LIABILITIES | $6.2B |
| TOTAL LIABILITIES | $22.6B |
| Common Stock | $397M |
| Additional Paid-In Capital | $1.5B |
| Retained Earnings | $14.9B |
| Treasury Stock | -$2.5B |
| Accum. Other Comp. Income | -$309M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $13.9B |
| Minority Interest | $0 |
| TOTAL EQUITY | $13.9B |
| TOTAL LIABILITIES & EQUITY | $36.5B |
| Total Debt | $875M |
| Net Debt | -$108M |
